Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors.

Abstract excerpt

Colorectal cancer (CRC) is a kind of solid tumor and the third most common cancer type in the world. It is a heterogeneous disease characterized by genetic and epigenetic aberrations. The TP53 mutation is the key step driving the transition from adenoma to adenocarcinoma. The functional roles of TP53 mutation in tumor development have been comprehensively investigated. In CRC, TP53 mutation was associated with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adenoma
• Share to Antineoplastic Agents